When discussing heart health, the words 'myocardial infarction' and 'heart attack' are used interchangeably as if they are ...

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

Myocardial infarction, commonly known as a heart attack, is one of the most serious heart problems people can face. It ...

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

A STEMI heart attack is the most serious kind because one of the heart’s main supply arteries is completely blocked. After ...

Revascularization of all vessels with stenosis was linked to lower rates of death, another MI, and further revascularization ...

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

Mount Nittany Health Emergency Medical Services has been honored with the American Heart Association’s 2025 Mission: Lifeline ...

In STEMI-induced cardiogenic shock, a microaxial flow pump can unload the heart by reducing native cardiac output and ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...

There is increased risk for incident myocardial infarction among adults aged 18 to 64 years with joint exposure to ozone and increased ambient temperature.